Evidence map›Paper›PMID 37111475›Full record

ArticlePathogens (Basel, Switzerland)2023

Epidemiological and Clinical Features of

Andreas Itzek, Victoria Weißbach, David Meintrup, Beate Rieß, Mark van der Linden, Stefan Borgmann

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Emerging trends in invasiveEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  2. Article
  3. Dominance of the ST20Microorganisms · 2026
    Article
  4. Genomic and patient epidemiology ofMicrobiology spectrum · 2026
    Article
  5. Analysis ofmBio · 2025
    Article
  6. Article
  7. Clinical microbiology reviews · 2024
    Review
  8. Clinical manifestations and biomarkers to predict mortality risk in adults with invasive Streptococcus dysgalactiae subsp. equisimilis infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Observational
  9. Multiple Drug ResistantAntibiotics (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Andreas ItzekGerman National Reference Center for Streptococci, Institute of Medical Microbiology, University Hospital RWTH Aachen, 52074 Aachen, Germany.
Victoria WeißbachDepartment of Infectious Diseases and Infection Control, Ingolstadt Hospital, 85049 Ingolstadt, Germany.
David MeintrupFaculty of Engineering and Management, University of Applied Sciences Ingolstadt, 85049 Ingolstadt, Germany.
Beate RießDepartment of Infectious Diseases and Infection Control, Ingolstadt Hospital, 85049 Ingolstadt, Germany.
Mark van der LindenGerman National Reference Center for Streptococci, Institute of Medical Microbiology, University Hospital RWTH Aachen, 52074 Aachen, Germany.
Stefan BorgmannDepartment of Infectious Diseases and Infection Control, Ingolstadt Hospital, 85049 Ingolstadt, Germany.
Klinikum Ingolstadt · DERWTH Aachen University · DETechnische Hochschule Ingolstadt · DE

Funding

Robert Koch Institute 1369-235
6 · The paper itself

Abstract

(1) Background:

Indexed as

clinical studyemm typeGermanySDSEstG62647Streptococcus dysgalactiae subspecies equisimilissurveillance

Identifiers

PMID37111475
PMCPMC10143538
OpenAlexW4365514337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.